 SOUTH SAN FRANCISCO, Calif., March 02, 2022 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the companys fourth quarter and full year 2021 financial results on Thursday, March 10, 2022 after the close of U.S. financial markets. 